Baidu
map

整形科指南

订阅

MedSci主页 / 所有栏目 / 整形科指南

中国瘢痕疙瘩临床治疗推荐指南

2018-05-20 中国整形美容协会 瘢痕医学分会常务委员会专家组 中国美容整形外科杂志.2018,29(5):前插5-1-12.

瘢痕疙瘩临床治疗

瘢痕疙瘩是整形外科、皮肤科和烧创伤外科领域的常见病。因其治疗后的高复发率和对治疗的抵抗性，瘢痕疙瘩成为外科和皮肤科领域临床难以治愈的疾病之一。随着现代医学技术的进步和对该疾病认识的进展，新的治疗理念创新和新治疗手段的应用为解决这一临床难题提供了可行的解决方案。由于目前国内外缺乏针对瘢痕疙瘩的临床治疗指南，中国整形美容协会瘢痕医学分会常务委员会专家组基于国内外文献报道和国内主要瘢痕治疗中心的临床治疗

中文标题：

中国瘢痕疙瘩临床治疗推荐指南

发布机构：

中国整形美容协会 瘢痕医学分会常务委员会专家组

发布日期：

2018-05-20

简要介绍：

瘢痕疙瘩是整形外科、皮肤科和烧创伤外科领域的常见病。因其治疗后的高复发率和对治疗的抵抗性，瘢痕疙瘩成为外科和皮肤科领域临床难以治愈的疾病之一。随着现代医学技术的进步和对该疾病认识的进展，新的治疗理念创新和新治疗手段的应用为解决这一临床难题提供了可行的解决方案。由于目前国内外缺乏针对瘢痕疙瘩的临床治疗指南，中国整形美容协会瘢痕医学分会常务委员会专家组基于国内外文献报道和国内主要瘢痕治疗中心的临床治疗经验，共同撰写了中国瘢痕疙瘩治疗推荐指南，为进一步提升我国瘢痕疙瘩治疗水平提供专家的指导性意见。 

拓展指南：与瘢痕相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=中国瘢痕疙瘩临床治疗推荐指南)] GetToolGuiderByIdResponse(projectId=1, id=977be1c00159e287, title=中国瘢痕疙瘩临床治疗推荐指南, enTitle=, guiderFrom=中国美容整形外科杂志.2018,29(5):前插5-1-12., authorId=null, author=, summary=瘢痕疙瘩是整形外科、皮肤科和烧创伤外科领域的常见病。因其治疗后的高复发率和对治疗的抵抗性，瘢痕疙瘩成为外科和皮肤科领域临床难以治愈的疾病之一。随着现代医学技术的进步和对该疾病认识的进展，新的治疗理念创新和新治疗手段的应用为解决这一临床难题提供了可行的解决方案。由于目前国内外缺乏针对瘢痕疙瘩的临床治疗指南，中国整形美容协会瘢痕医学分会常务委员会专家组基于国内外文献报道和国内主要瘢痕治疗中心的临床治疗, cover=, journalId=null, articlesId=null, associationId=1660, associationName=中国整形美容协会 瘢痕医学分会常务委员会专家组, associationIntro=, copyright=0, guiderPublishedTime=Sun May 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>瘢痕疙瘩是整形外科、皮肤科和烧创伤外科领域的常见病。因其治疗后的高复发率和对治疗的抵抗性，瘢痕疙瘩成为外科和皮肤科领域临床难以治愈的疾病之一。随着现代医学技术的进步和对该疾病认识的进展，新的治疗理念创新和新治疗手段的应用为解决这一临床难题提供了可行的解决方案。由于目前国内外缺乏针对瘢痕疙瘩的临床治疗指南，中国整形美容协会瘢痕医学分会常务委员会专家组基于国内外文献报道和国内主要瘢痕治疗中心的临床治疗经验，共同撰写了中国瘢痕疙瘩治疗推荐指南，为进一步提升我国瘢痕疙瘩治疗水平提供专家的指导性意见。 </div> <div><br> </div>拓展指南：<strong>与<font color="red">瘢痕</font>相关指南：</strong><br><ul><li><a title="中国临床瘢痕防治专家共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=f297f1c0015a3e25">中国临床瘢痕防治专家共识</a></li> <li><a title="2016 剖宫产术后子宫瘢痕妊娠诊治专家共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=80b101c001298232">2016 剖宫产术后子宫瘢痕妊娠诊治专家共识</a></li> <li><a title="2012 剖宫产瘢痕妊娠诊断与治疗共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=883381c0009205fd">2012 剖宫产瘢痕妊娠诊断与治疗共识</a></li> 更多信息请点击：<a target="_blank" href="//m.capotfarm.com/guideline/list.do?q=%E7%98%A2%E7%97%95">有关瘢痕更多指南</a></ul>, tagList=[TagDto(tagId=75554, tagName=瘢痕疙瘩), TagDto(tagId=17598, tagName=临床治疗)], categoryList=[CategoryDto(categoryId=28, categoryName=整形科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=26623, appHits=657, showAppHits=0, pcHits=11590, showPcHits=15964, likes=172, shares=32, comments=11, approvalStatus=1, publishedTime=Mon May 28 22:30:18 CST 2018, publishedTimeString=2018-05-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon May 28 22:30:18 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:01:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国瘢痕疙瘩临床治疗推荐指南)])
中国瘢痕疙瘩临床治疗推荐指南
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1016894, encodeId=591b101689429, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b64e5313243, createdName=14890b85m58暂无昵称, createdTime=Sun Sep 12 23:39:24 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961089, encodeId=30e696108927, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a05487264, createdName=ms3000000626202845, createdTime=Wed Apr 28 05:08:49 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954980, encodeId=59999549808c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b15307303, createdName=1487cc94m98暂无昵称, createdTime=Wed Apr 07 18:11:05 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913490, encodeId=0b4a9134907e, content=值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa65449736, createdName=ms8000001117928829, createdTime=Mon Jan 04 08:58:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904140, encodeId=deb890414087, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Wed Dec 02 09:08:05 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-09-12 14890b85m58暂无昵称

    牛逼

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1016894, encodeId=591b101689429, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b64e5313243, createdName=14890b85m58暂无昵称, createdTime=Sun Sep 12 23:39:24 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961089, encodeId=30e696108927, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a05487264, createdName=ms3000000626202845, createdTime=Wed Apr 28 05:08:49 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954980, encodeId=59999549808c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b15307303, createdName=1487cc94m98暂无昵称, createdTime=Wed Apr 07 18:11:05 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913490, encodeId=0b4a9134907e, content=值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa65449736, createdName=ms8000001117928829, createdTime=Mon Jan 04 08:58:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904140, encodeId=deb890414087, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Wed Dec 02 09:08:05 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-04-28 ms3000000626202845

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1016894, encodeId=591b101689429, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b64e5313243, createdName=14890b85m58暂无昵称, createdTime=Sun Sep 12 23:39:24 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961089, encodeId=30e696108927, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a05487264, createdName=ms3000000626202845, createdTime=Wed Apr 28 05:08:49 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954980, encodeId=59999549808c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b15307303, createdName=1487cc94m98暂无昵称, createdTime=Wed Apr 07 18:11:05 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913490, encodeId=0b4a9134907e, content=值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa65449736, createdName=ms8000001117928829, createdTime=Mon Jan 04 08:58:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904140, encodeId=deb890414087, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Wed Dec 02 09:08:05 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-04-07 1487cc94m98暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1016894, encodeId=591b101689429, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b64e5313243, createdName=14890b85m58暂无昵称, createdTime=Sun Sep 12 23:39:24 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961089, encodeId=30e696108927, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a05487264, createdName=ms3000000626202845, createdTime=Wed Apr 28 05:08:49 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954980, encodeId=59999549808c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b15307303, createdName=1487cc94m98暂无昵称, createdTime=Wed Apr 07 18:11:05 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913490, encodeId=0b4a9134907e, content=值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa65449736, createdName=ms8000001117928829, createdTime=Mon Jan 04 08:58:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904140, encodeId=deb890414087, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Wed Dec 02 09:08:05 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-01-04 ms8000001117928829

    值得借鉴

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1016894, encodeId=591b101689429, content=牛逼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b64e5313243, createdName=14890b85m58暂无昵称, createdTime=Sun Sep 12 23:39:24 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961089, encodeId=30e696108927, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a05487264, createdName=ms3000000626202845, createdTime=Wed Apr 28 05:08:49 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954980, encodeId=59999549808c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63b15307303, createdName=1487cc94m98暂无昵称, createdTime=Wed Apr 07 18:11:05 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913490, encodeId=0b4a9134907e, content=值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa65449736, createdName=ms8000001117928829, createdTime=Mon Jan 04 08:58:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904140, encodeId=deb890414087, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/13/9e868433697f9337bc9c6b44718fa935.jpg, createdBy=e0062060044, createdName=公冶花, createdTime=Wed Dec 02 09:08:05 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-02 公冶花

    学习了

    0

Baidu
map
Baidu
map
Baidu
map